Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001771910-22-000004
Filing Date
2022-03-17
Accepted
2022-03-17 08:24:40
Documents
204
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F adc-20211231.htm   iXBRL 20-F 5355306
2 EX-2.1 ex21descriptionofsecurities.htm EX-2.1 155983
3 EX-4.15 ex415-japanagreement.htm EX-4.15 568288
4 EX-8.1 ex81-subsidiarylist.htm EX-8.1 3785
5 EX-12.1 ex121-ceocertification302.htm EX-12.1 10097
6 EX-12.2 ex122-cfocertification302.htm EX-12.2 10350
7 EX-13.1 ex131-ceocertification906.htm EX-13.1 4894
8 EX-13.2 ex132-cfocertification906.htm EX-13.2 5005
9 EX-15.1 ex151-consent.htm EX-15.1 2217
15 adc-20211231_g1.jpg GRAPHIC 89225
16 adc-20211231_g10.jpg GRAPHIC 64875
17 adc-20211231_g11.jpg GRAPHIC 35136
18 adc-20211231_g12.jpg GRAPHIC 50719
19 adc-20211231_g13.jpg GRAPHIC 34126
20 adc-20211231_g14.jpg GRAPHIC 38111
21 adc-20211231_g15.jpg GRAPHIC 767668
22 adc-20211231_g16.jpg GRAPHIC 765031
23 adc-20211231_g17.jpg GRAPHIC 16899
24 adc-20211231_g18.jpg GRAPHIC 60794
25 adc-20211231_g19.jpg GRAPHIC 365593
26 adc-20211231_g2.jpg GRAPHIC 68341
27 adc-20211231_g20.jpg GRAPHIC 59347
28 adc-20211231_g21.jpg GRAPHIC 45908
29 adc-20211231_g22.jpg GRAPHIC 35439
30 adc-20211231_g23.jpg GRAPHIC 52167
31 adc-20211231_g24.jpg GRAPHIC 35395
32 adc-20211231_g25.jpg GRAPHIC 36393
33 adc-20211231_g26.jpg GRAPHIC 87313
34 adc-20211231_g27.jpg GRAPHIC 24042
35 adc-20211231_g28.jpg GRAPHIC 21315
36 adc-20211231_g29.jpg GRAPHIC 32718
37 adc-20211231_g3.jpg GRAPHIC 402415
38 adc-20211231_g30.jpg GRAPHIC 20927
39 adc-20211231_g31.jpg GRAPHIC 76336
40 adc-20211231_g32.jpg GRAPHIC 26753
41 adc-20211231_g33.jpg GRAPHIC 57365
42 adc-20211231_g34.jpg GRAPHIC 32976
43 adc-20211231_g35.jpg GRAPHIC 67364
44 adc-20211231_g36.jpg GRAPHIC 29619
45 adc-20211231_g37.jpg GRAPHIC 48950
46 adc-20211231_g4.jpg GRAPHIC 80485
47 adc-20211231_g5.jpg GRAPHIC 32600
48 adc-20211231_g6.jpg GRAPHIC 55478
49 adc-20211231_g7.jpg GRAPHIC 91961
50 adc-20211231_g8.jpg GRAPHIC 55440
51 adc-20211231_g9.jpg GRAPHIC 96906
  Complete submission text file 0001771910-22-000004.txt   31238661

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adc-20211231.xsd EX-101.SCH 190947
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adc-20211231_cal.xml EX-101.CAL 124260
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adc-20211231_def.xml EX-101.DEF 645896
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adc-20211231_lab.xml EX-101.LAB 1436623
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adc-20211231_pre.xml EX-101.PRE 957380
198 EXTRACTED XBRL INSTANCE DOCUMENT adc-20211231_htm.xml XML 4273733
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39071 | Film No.: 22746852
SIC: 2834 Pharmaceutical Preparations